RT Book, Section
A1 Holtan, Elizabeth E.
A2 Freeman, Brian S.
A2 Berger, Jeffrey S.
SR Print(0)
ID 1102567089
T1 Etomidate
T2 Anesthesiology Core Review: Part One Basic Exam
YR 2014
FD 2014
PB McGraw-Hill Education
PP New York, NY
SN 9780071821377
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1102567089
RD 2024/04/19
AB First  introduced  into  clinical  practice  in  1972,  etomidate  has  a  long  history  of  use  as  an  intravenous  anesthetic  and  sedative.  Like  propofol,  etomidate  has  a  hypnotic  effect  but  does  not  provide  any  analgesia.  It  is  preferred  primarily  for  its  stable  effect  on  circulatory  hemodynamics  in  patients  with  decreased  myocardial  contractility.  Etomidate  is  also  indicated  for  anesthetic  induction  in  patients  with  severe  neurologic  disease,  such  as  elevated  intracranial  hypertension,  who  require  maintenance  of  cerebral  perfusion  pressure.  Etomidate  may  also  be  particularly  useful  as  an  anesthetic  for  emergency  intubation  in  ICU  or  trauma  patients.